, Columnist
Celgene May Be Ready to Lap Bristol
At least in this case, big biotech is beating big pharma.
This article is for subscribers only.
The distinction between big biotech and big pharma has grown increasingly moot as several biotechs have gotten larger than their much older peers.
That might soon happen again, with biotech giant Celgene Corp. approaching the size of big-pharma stalwart Bristol-Myers Squibb Co.